Innoforce Pharmaceuticals Funding: $120M Raised, Series A
Innoforce Pharmaceuticals is based in Hangzhou, Zhejiang, China. It has raised $120M in total funding. Latest round: Series A.
Innoforce Pharmaceuticals funding overview
Innoforce Pharmaceuticals is based in Hangzhou, Zhejiang, China. Innoforce Pharmaceuticals has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in March 2021. The round record for Innoforce Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include South China Venture Capital, Yanchuang Capital, Quan Capital Management, Advantech Capital, CICC Capital Management. 5 distinct backers are named across the disclosed rounds.
Innoforce Pharmaceuticals at a glance
Total raised
$120M
Latest round
Series A
Latest round date
March 2021
Headquarters
Hangzhou, Zhejiang, China
Notable investors
South China Venture Capital, Yanchuang Capital, Quan Capital Management, Advantech Capital, CICC Capital Management
Frequently asked about Innoforce Pharmaceuticals funding
How much has Innoforce Pharmaceuticals raised?
Innoforce Pharmaceuticals has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Innoforce Pharmaceuticals?
South China Venture Capital, Yanchuang Capital, Quan Capital Management, Advantech Capital, CICC Capital Management are named among the investors backing Innoforce Pharmaceuticals.
What was the latest Innoforce Pharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in March 2021.
Where is Innoforce Pharmaceuticals based?
Innoforce Pharmaceuticals is based in Hangzhou, Zhejiang, China.
When did Innoforce Pharmaceuticals last raise?
The last disclosed Innoforce Pharmaceuticals round closed in March 2021 at Series A.
Innoforce Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Hangzhou below to benchmark round size and investor mix.
Companies related to Innoforce Pharmaceuticals (20)
